
Zepp Health (ZEPP) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
38.5M
Gross Profit
14.4M
37.27%
Operating Income
-18.4M
-47.68%
Net Income
-19.7M
-51.23%
EPS (Diluted)
$-1.28
Balance Sheet Metrics
Total Assets
518.8M
Total Liabilities
286.7M
Shareholders Equity
232.0M
Debt to Equity
1.24
Cash Flow Metrics
Operating Cash Flow
-14.6M
Free Cash Flow
-16.9M
Revenue & Profitability Trend
Zepp Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 182.6M | 352.0M | 600.5M | 980.5M | 984.7M |
Cost of Goods Sold | 112.4M | 259.2M | 484.1M | 775.7M | 780.7M |
Gross Profit | 70.2M | 92.8M | 116.4M | 204.8M | 204.0M |
Gross Margin % | 38.5% | 26.4% | 19.4% | 20.9% | 20.7% |
Operating Expenses | |||||
Research & Development | 46.2M | 51.0M | 75.0M | 80.8M | 82.3M |
Selling, General & Administrative | 71.3M | 71.0M | 100.9M | 109.3M | 95.0M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 117.5M | 122.0M | 175.9M | 190.1M | 177.3M |
Operating Income | -47.2M | -29.2M | -59.5M | 14.7M | 26.7M |
Operating Margin % | -25.9% | -8.3% | -9.9% | 1.5% | 2.7% |
Non-Operating Items | |||||
Interest Income | 3.7M | 3.1M | 1.8M | 2.6M | 7.1M |
Interest Expense | 5.6M | 6.7M | 8.3M | 7.0M | 3.5M |
Other Non-Operating Income | -8.8M | -549.5K | 11.9M | 6.4M | 10.4M |
Pre-tax Income | -57.9M | -33.4M | -54.0M | 16.7M | 40.7M |
Income Tax | 13.7M | -2.2M | -9.5M | 1.7M | 4.8M |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 10.1% | 11.7% |
Net Income | -75.8M | -30.0M | -41.9M | 21.5M | 35.2M |
Net Margin % | -41.5% | -8.5% | -7.0% | 2.2% | 3.6% |
Key Metrics | |||||
EBITDA | -39.2M | -19.0M | -42.8M | 29.8M | 37.7M |
EPS (Basic) | $-4.64 | $-1.96 | $-2.71 | $1.38 | $2.25 |
EPS (Diluted) | $-4.64 | $-1.96 | $-2.71 | $1.31 | $2.16 |
Basic Shares Outstanding | 16179758 | 110716521 | 111788002 | 114458880 | 112780845 |
Diluted Shares Outstanding | 16179758 | 110716521 | 111788002 | 114458880 | 112780845 |
Income Statement Trend
Zepp Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 91.1M | 133.9M | 128.5M | 230.4M | 348.0M |
Short-term Investments | 997.0K | 5.2M | 5.0M | 3.8M | 3.6M |
Accounts Receivable | 63.0M | 60.8M | 98.9M | 84.3M | 45.6M |
Inventory | 56.8M | 85.0M | 148.1M | 196.0M | 186.4M |
Other Current Assets | - | - | - | - | - |
Total Current Assets | 251.6M | 317.2M | 428.8M | 616.7M | 739.0M |
Non-Current Assets | |||||
Property, Plant & Equipment | 3.5M | 6.8M | 9.5M | 17.0M | 23.1M |
Goodwill | 26.3M | 29.1M | 37.0M | 40.4M | 41.4M |
Intangible Assets | 7.1M | 9.9M | 17.9M | 21.3M | 22.2M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 26.1M | 48.1M | 39.6M | 25.6M | 22.7M |
Total Non-Current Assets | 277.0M | 319.3M | 334.7M | 338.0M | 164.7M |
Total Assets | 528.6M | 636.5M | 763.5M | 954.7M | 903.6M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 51.1M | 37.3M | 66.2M | 206.7M | 298.7M |
Short-term Debt | 104.9M | 72.7M | 146.5M | 80.3M | 84.6M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 3.0M | 3.0M | 3.1M | 4.4M | 4.9M |
Total Current Liabilities | 195.4M | 155.4M | 241.9M | 337.6M | 427.0M |
Non-Current Liabilities | |||||
Long-term Debt | 77.2M | 123.4M | 103.8M | 125.2M | 27.0M |
Deferred Tax Liabilities | 3.1M | 4.2M | 5.2M | 4.2M | 3.4M |
Other Non-Current Liabilities | 133.0K | 270.3K | 23.6M | 27.5M | 28.3M |
Total Non-Current Liabilities | 80.5M | 127.9M | 132.5M | 156.9M | 58.7M |
Total Liabilities | 275.9M | 283.2M | 374.3M | 494.5M | 485.7M |
Equity | |||||
Common Stock | 26.0K | 23.1K | 23.5K | 24.9K | 24.0K |
Retained Earnings | 28.6M | 103.1M | 136.7M | 199.4M | 173.5M |
Treasury Stock | 15.0M | 12.0M | 9.7M | 3.4M | 0 |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 252.7M | 353.3M | 389.2M | 460.2M | 417.9M |
Key Metrics | |||||
Total Debt | 182.1M | 196.1M | 250.3M | 205.5M | 111.6M |
Working Capital | 56.2M | 161.9M | 187.0M | 279.1M | 312.0M |
Balance Sheet Composition
Zepp Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -75.8M | -30.0M | -41.9M | 21.5M | 35.2M |
Depreciation & Amortization | 5.0M | 7.7M | 8.5M | 8.1M | 4.2M |
Stock-Based Compensation | 4.8M | 8.4M | 7.1M | 13.0M | 10.0M |
Working Capital Changes | 25.1M | 41.7M | -108.4M | -77.1M | 10.0M |
Operating Cash Flow | -26.0M | 30.0M | -138.2M | -30.8M | 65.1M |
Investing Activities | |||||
Capital Expenditures | -707.0K | 6.2K | -1.2M | -6.8M | -12.8M |
Acquisitions | 0 | 389.9K | 0 | 5.3M | -5.3M |
Investment Purchases | -7.0M | -282.1K | -4.2M | -169.1M | -45.0M |
Investment Sales | 5.2M | 5.9M | 1.7M | 3.9M | 31.7M |
Investing Cash Flow | -2.5M | 4.6M | -5.9M | -166.7M | -31.5M |
Financing Activities | |||||
Share Repurchases | -2.3M | -2.5M | -7.7M | -2.2M | 0 |
Dividends Paid | 0 | 0 | -5.8M | 0 | 0 |
Debt Issuance | 11.0M | 56.8M | 121.6M | 231.2M | 184.9M |
Debt Repayment | -12.6M | -103.7M | -105.4M | -149.6M | -98.4M |
Financing Cash Flow | 477.0K | -41.6M | 41.9M | 85.6M | 651.1M |
Free Cash Flow | -25.9M | 40.5M | -115.6M | -44.8M | 11.1M |
Net Change in Cash | -28.0M | -7.0M | -102.2M | -111.9M | 684.7M |
Cash Flow Trend
Zepp Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-2.80
Forward P/E
-1,300.00
Price to Book
0.80
Price to Sales
1.03
PEG Ratio
-1,300.00
Profitability Ratios
Profit Margin
-44.54%
Operating Margin
-47.68%
Return on Equity
-28.56%
Return on Assets
-5.65%
Financial Health
Current Ratio
1.14
Debt to Equity
46.23
Beta
0.85
Per Share Data
EPS (TTM)
$-4.96
Book Value per Share
$16.15
Revenue per Share
$11.23
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
zepp | 186.8M | -2.80 | 0.80 | -28.56% | -44.54% | 46.23 |
Apple | 3.0T | 30.66 | 45.67 | 149.81% | 24.30% | 154.49 |
Sony | 148.1B | 19.34 | 0.02 | 14.18% | 8.81% | 49.26 |
GoPro | 189.1M | 21.21 | 1.72 | -83.57% | -17.93% | 132.95 |
Voxx International | 169.0M | -4.31 | 0.67 | -33.66% | -18.06% | 12.06 |
Vuzix | 147.9M | -1.80 | 4.50 | -136.11% | -97.31% | 1.09 |
Financial data is updated regularly. All figures are in the company's reporting currency.